TST003 / Transcenta 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TST003 / Transcenta
NCT05731271: A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors

Recruiting
1/2
76
US
TST003
Suzhou Transcenta Therapeutics Co., Ltd.
Locally Advanced Solid Tumor, Metastatic Tumor, Colorectal Adenocarcinoma
05/25
08/25

Download Options